Investor's Business Daily on MSN
The next wave of peptides could be here; what does it mean for Lilly, Novo?
FDA advisors will debate the merits of seven peptides next week. The discussion could have an impact on Eli Lilly and Novo Nordisk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results